Novo Nordisk AS (NYSE:NVO)
$ 106.13 0 (0%) Market Cap: 471.52 Bil Enterprise Value: 469.00 Bil PE Ratio: 34.18 PB Ratio: 28.00 GF Score: 95/100

Q4 2021 Novo Nordisk A/S Earnings Call (London-Based Investors) Transcript

Feb 04, 2022 / 11:00AM GMT
Release Date Price: $49.84 (-4.74%)
Operator

Hello, everyone, and welcome to the Q4 2021 Novo Nordisk A/S Earnings Presentation. (Operator Instructions)

Today, I'm pleased to present Lars Fruergaard Jorgensen. Please go ahead with your meeting.

Lars Fruergaard Jorgensen;S;President
Novo Nordisk A;CEO & Member of Management Board

/- -

Thank you very much. And let me start by thanking Bank of America and Sachin Jain for hosting us today. First slide is our forward-looking statements. So I remind you that we'll be talking about the future, and it might turn out to be different than what we preach.

Looking at the highlights for the full year of 2021. We are very pleased with how we have executed on all 4 quadrants of our strategic aspirations. We'll cover most of it today. But just on this slide, we mentioned that on ESG, we're very pleased in how we are living up to both our social and environmental responsibilities, making good progress there. And the other quadrants, you will hear about as we present.

So if you go to the next slide,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot